Hanu Tyagi

Hanu Tyagi

Assistant Professor of Business Administration

  • Email
  • LinkedIn

Contact

3048 Business Instructional Facility

515 Gregory Dr

Champaign, IL 61820

hanu@illinois.edu

Vita

Update Your Profile Refresh Your Profile

Listings

Educational Background

  • Ph.D., Supply Chain & Operations, Carlson School of Management, University of Minnesota, 2024
  • Post Graduate Programme, Management, Indian School of Business, 2013
  • B.T., Mechanical Engineering, National Institute of Technology, 2008

Positions Held

  • Assistant Professor of Business Administration, Business Administration, University of Illinois at Urbana-Champaign, 2024 to present

Recent Publications

  • Hietlage, V., Farley, J., Shah, R., Tyagi, H., & Stenehjem, D. (2022). EPH138 Post-Marketing Adverse Events of Oncology Medications with Breakthrough Therapy Designation Correlated with Time on Market and Market Share. Value in Health.  link >
  • Tyagi, H., Sabharwal, M., Dixit, N., Pal, A., & Deo, S. (2020). Leveraging Providers’ Preferences to Customize Instructional Content in Information and Communications Technology- Based Training Interventions: Retrospective Analysis of a Mobile Phone-Based Intervention in India JMIR mHealth and uHealth.  link >
  • Deo, s., Tyagi, H., Chatterjee, C., & Molakapuri, H. (2020). Did India’s price control policy for coronary stents create unintended consequences? Social Science & Medicine.  link >
  • Tyagi, H. (2018). Digital Health Start-ups: The Challenge of Scale. ISBInsight.

Other Publications

Articles

  • Deo, S., & Tyagi, H. (2018). Rx ICT: Digitally Disrupting Healthcare. ISBInsight.
  • Powell, A., Tyagi, H., & Ludhar, J. (2018). Digitising Indian healthcare records. ISBInsight.
  • Tyagi, H. (2018). Taking Off: Digital Health Start-ups in India. ISBInsight.

Conference Proceedings

  • Tyagi, H., Hermosilla, M., & Shah, R. (2023). How does Transparency Impact Technological Novelty? Evidence from Large Pharmaceutical Firms. Academy of Management Proceedings.  link >

Working Papers

  • Tyagi, H., Hermosilla, M., & Shah, R. Does Transparency Hinder Technological Novelty? Evidence From Large Pharmaceutical Firms.
  • Tyagi, H., & Shah, R. Balancing Speed-Safety Tradeoffs in the Drug Approval Process.

Teaching Interests

Operations Management
Supply Chain Management

Research Interests

Drug innovation & new product development
Drug stockouts & shortages
Drug quality Management
Pharma supply chain transparency

Contact

3048 Business Instructional Facility

515 Gregory Dr

Champaign, IL 61820

hanu@illinois.edu

Vita

Update Your Profile Refresh Your Profile